Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood cancer
Pharma
Trial results show value of Lilly's Jaypirca in front-line CLL
By nailing the primary endpoint in a trial of Jaypirca, Eli Lilly has brought the drug closer to becoming available to a broader group of patients.
Kevin Dunleavy
Sep 8, 2025 11:37am
Cancer nonprofit rebrands, runs first national campaign in years
Aug 28, 2025 11:45am
ExCellThera's blood cancer cell therapy Zemcelpro earns EU nod
Aug 27, 2025 7:40am
ExCellThera's novel blood cancer cell therapy gains CHMP nod
Jun 20, 2025 11:55am
Pfizer's blockbuster ADC Adcetris nabs FDA nod in LBCL
Feb 12, 2025 3:06pm
PharmaEssentia plots expansion for blood cancer med Besremi
Jan 7, 2025 9:00am
